EcoDrugPlus

Adrenoceptor Alpha 1b

Ensembl ID : ENSBBBG00000005874
Gene Symbol: ADRA1B
1 Cross references
265 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSBBBG00000020042
Gene Symbol: ADRA1D
3 Cross references
196 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSBBBG00000009559
Gene Symbol: ADRA2A
3 Cross references
227 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSBBBG00000024872
Gene Symbol: ADRA2B
3 Cross references
222 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSBBBG00000009752
Gene Symbol: ADRB1
1 Cross references
163 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSBBBG00000008077
Gene Symbol: ADRB2
3 Cross references
265 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSBBBG00000008119
Gene Symbol: AGER
3 Cross references
170 Possible Orthologues:

Alcohol Dehydrogenase 5 (Class Iii), Chi Polypeptide

Ensembl ID : ENSBBBG00000022169
Gene Symbol: ADH5
3 Cross references
405 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSBBBG00000015030
Gene Symbol: AKR1B1
2 Cross references
400 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSBBBG00000010915
Gene Symbol: LOC104989288
2 Cross references
400 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSBBBG00000018270
Gene Symbol: GAA
3 Cross references
233 Possible Orthologues:

Alpha-Amylase 2b

Ensembl ID : ENSBBBG00000009301
Gene Symbol: LOC104981710
2 Cross references
200 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).